CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis
Journal of Molecular Cell Biology · 2024
DOI: 10.1093/jmcb/mjad057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2024. Verfasst von Haixia Cheng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Cell Proliferation, Polycomb Repressive Complex 1, Meningioma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Meningioma is one of the most common primary neoplasms in the central nervous system, but no specific molecularly targeted therapy has been approved for the clinical treatment of aggressive meningiomas. There is hence an urgent demand to decrypt the biological and molecular landscape of malignant meningioma. Here, through the in-silica prescreening and 10-year follow-up studies of 445 meningioma patients, we uncovered that CBX7 expression progressively decreases with malignancy grade and neoplasia stage in meningioma, and a high CBX7 expression level predicts a favorable prognosis in meningioma patients. CBX7 restoration significantly induces cell cycle arrest and inhibits meningioma cell proliferation. iTRAQ-based proteomics analysis indicated that CBX7 restoration triggers the metabolic shift from glycolysis to oxidative phosphorylation. The mechanistic study demonstrated that CBX7 promotes the proteasome-dependent degradation of c-MYC protein by transcriptionally inhibiting the expression of a c-MYC deubiquitinase, USP44, consequently attenuates c-MYC-mediated transactivation of LDHA transcripts, and further inhibits glycolysis and subsequent cell proliferation. More importantly, the functional role of CBX7 was further confirmed in subcutaneous and orthotopic meningioma xenograft mouse models and meningioma patients. Altogether, our results shed light on the critical role of CBX7 in meningioma malignancy progression and identify the CBX7/USP44/c-MYC/LDHA axis as a promising therapeutic target against meningioma progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
- Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
- Xinjiang Key Laboratory of Biology Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830046, China.
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cheng, H., Hua, L., Tang, H., Bao, Z., Xu, X., Zhu, H., Wang, S., Jiapaer, Z., Bhatia, R., Dunn, I. F., Deng, J., Wang, D., Sun, S., Luan, S., Ji, J., Xie, Q., Yang, X., Lei, J., Li, G., …, & Gong, Y. (2024). CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjad057
Vancouver
Cheng H, Hua L, Tang H, Bao Z, Xu X, Zhu H, et al. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis. Journal of Molecular Cell Biology. 2024. doi:10.1093/jmcb/mjad057
BibTeX
@article{Cheng2024,
author = {Cheng, Haixia and Hua, Lingyang and Tang, Hailiang and Bao, Zhongyuan and Xu, Xiupeng and Zhu, Hongguang and Wang, Shuyang and Jiapaer, Zeyidan and Bhatia, Roma and Dunn, Ian F and Deng, Jiaojiao and Wang, Daijun and Sun, Shuchen and Luan, Shihai and Ji, Jing and Xie, Qing and Yang, Xinyu and Lei, Ji and Li, Guoping and Wang, Xianli and Gong, Ye},
title = {CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis},
journal = {Journal of Molecular Cell Biology},
year = {2024},
doi = {10.1093/jmcb/mjad057}
}
EUVIMED